Literature DB >> 16584794

Adverse effect of a distended rectum in intensity-modulated radiotherapy (IMRT) treatment planning of prostate cancer.

Matthias Guckenberger1, Fabian Pohl, Kurt Baier, Juergen Meyer, Dirk Vordermark, Michael Flentje.   

Abstract

BACKGROUND AND
PURPOSE: The retrospective planning study for intensity-modulated radiotherapy (IMRT) of prostate cancer evaluated whether proximal rectum and supra-anal rectum/anal canal should be delineated as separated organs-at-risk (OARs) to achieve optimal dose distributions to the anorectal region. PATIENTS AND METHODS: For 10 patients with localized prostate cancer IMRT plans were generated with the rectum and anal canal as separated OARs (Rec-sep) and as one single OAR (Rec-tot). Two different treatment planning systems (TPS) were utilized. Influence on dose distributions to target and OARs was analyzed.
RESULTS: Results from both TPS showed significantly increased doses to the distal rectum/anal canal for plans Rec-tot compared with Rec-sep in case of a distended rectum in the planning CT study: doses were increased by up to mean 31% (P = 0.02) and 18% (P = 0.03), respectively, in both TPS. For the patient with the largest rectum, the maximum dose increase was 61%. No significant differences in doses to target, bladder, femoral head and proximal rectum were seen.
CONCLUSIONS: For patients with a distended rectum in the planning CT, delineation of separated OARs for proximal rectum and distal rectum/anal canal resulted in superior dose distributions to the anorectal region and therefore, we recommend this as standard procedure for IMRT planning of prostate cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16584794     DOI: 10.1016/j.radonc.2006.03.004

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

Review 1.  Image-guided radiotherapy: a new dimension in radiation oncology.

Authors:  Florian Sterzing; Rita Engenhart-Cabillic; Michael Flentje; Jürgen Debus
Journal:  Dtsch Arztebl Int       Date:  2011-04-22       Impact factor: 5.594

2.  Preliminary experience of a predictive model to define rectal volume and rectal dose during the treatment of prostate cancer.

Authors:  M D Falco; M D'Andrea; D Fedele; R Barbarino; M Benassi; E Giudice; E Hamoud; G Ingrosso; P Ladogana; F Santarelli; G Tortorelli; R Santoni
Journal:  Br J Radiol       Date:  2011-09       Impact factor: 3.039

3.  Analysis of inter-fraction setup errors and organ motion by daily kilovoltage cone beam computed tomography in intensity modulated radiotherapy of prostate cancer.

Authors:  Marcella Palombarini; Stefano Mengoli; Paola Fantazzini; Cecilia Cadioli; Claudio Degli Esposti; Giovanni Piero Frezza
Journal:  Radiat Oncol       Date:  2012-04-02       Impact factor: 3.481

4.  Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.

Authors:  Matthias Guckenberger; Jürgen Meyer; Kurt Baier; Dirk Vordermark; Michael Flentje
Journal:  Radiat Oncol       Date:  2006-09-06       Impact factor: 3.481

Review 5.  ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.

Authors:  Nicholas G Zaorsky; Timothy N Showalter; Gary A Ezzell; Paul L Nguyen; Dean G Assimos; Anthony V D'Amico; Alexander R Gottschalk; Gary S Gustafson; Sameer R Keole; Stanley L Liauw; Shane Lloyd; Patrick W McLaughlin; Benjamin Movsas; Bradley R Prestidge; Al V Taira; Neha Vapiwala; Brian J Davis
Journal:  Adv Radiat Oncol       Date:  2016-10-20

6.  Geometric and dosimetric evaluation of the differences between rigid and deformable registration to assess interfraction motion during pelvic radiotherapy.

Authors:  Ingrid White; Dualta McQuaid; Helen McNair; Alex Dunlop; Steven Court; Naomi Hopkins; Karen Thomas; David Dearnaley; Shree Bhide; Susan Lalondrelle
Journal:  Phys Imaging Radiat Oncol       Date:  2019-04-05

Review 7.  ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II.

Authors:  Nicholas G Zaorsky; Timothy N Showalter; Gary A Ezzell; Paul L Nguyen; Dean G Assimos; Anthony V D'Amico; Alexander R Gottschalk; Gary S Gustafson; Sameer R Keole; Stanley L Liauw; Shane Lloyd; Patrick W McLaughlin; Benjamin Movsas; Bradley R Prestidge; Al V Taira; Neha Vapiwala; Brian J Davis
Journal:  Adv Radiat Oncol       Date:  2017-03-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.